Both in Pharmaceuticals
Gain Therapeutics vs iBio
Over the past year GANX returned −33.1% and IBIO returned −47.7%; their daily moves had a correlation of 0.19.
GANX −33.1% IBIO −47.7%Growth of $1, one year, split-adjusted
| Metric | GANX | IBIO |
|---|---|---|
| Price | $1.11 | $0.8000 |
| Market cap | $48.4M | $51.4M |
| Today | −3.48% | −2.85% |
| 1 month | −33.5% | −23.8% |
| 6 months | −41.9% | −54.8% |
| Year to date | −65.5% | −58.5% |
| 1 year | −39.7% | −54.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 514.5× |
| Net cash | $12.7M | $88.0M |
| Dividend yield | — | — |
| Volatility (60d) | 55.4% | 65.6% |
| Short % of float | 7.6% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).